BidaskClub upgraded shares of LeMaitre Vascular (NASDAQ:LMAT) from a sell rating to a hold rating in a research note published on Wednesday morning.

Other analysts also recently issued reports about the stock. Zacks Investment Research raised shares of LeMaitre Vascular from a hold rating to a buy rating and set a $35.00 price objective on the stock in a report on Tuesday, October 31st. Stifel Nicolaus reiterated a buy rating on shares of LeMaitre Vascular in a research note on Sunday, October 29th. Canaccord Genuity decreased their target price on shares of LeMaitre Vascular from $30.00 to $29.00 and set a hold rating for the company in a research note on Friday, October 27th. Benchmark cut shares of LeMaitre Vascular from a buy rating to a hold rating in a research note on Friday, October 27th. Finally, First Analysis cut shares of LeMaitre Vascular from an overweight rating to an equal weight rating and set a $34.00 target price for the company. in a research note on Friday, October 27th. Seven investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The stock has a consensus rating of Hold and a consensus target price of $32.20.

Shares of LeMaitre Vascular (LMAT) opened at $35.17 on Wednesday. The company has a market cap of $680.63, a price-to-earnings ratio of 45.68, a PEG ratio of 2.72 and a beta of 0.53. LeMaitre Vascular has a twelve month low of $19.82 and a twelve month high of $39.88.

In related news, insider David B. Roberts sold 4,123 shares of the business’s stock in a transaction on Monday, November 6th. The shares were sold at an average price of $32.14, for a total value of $132,513.22. Following the completion of the transaction, the insider now directly owns 24,482 shares in the company, valued at approximately $786,851.48. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 23.70% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the stock. 361 Capital LLC acquired a new position in shares of LeMaitre Vascular in the 3rd quarter valued at $1,973,000. BNP Paribas Arbitrage SA raised its position in LeMaitre Vascular by 97.6% during the third quarter. BNP Paribas Arbitrage SA now owns 7,405 shares of the medical instruments supplier’s stock worth $277,000 after acquiring an additional 3,657 shares during the period. Allianz Asset Management GmbH raised its position in LeMaitre Vascular by 4.7% during the third quarter. Allianz Asset Management GmbH now owns 321,820 shares of the medical instruments supplier’s stock worth $12,042,000 after acquiring an additional 14,306 shares during the period. Dimensional Fund Advisors LP raised its position in LeMaitre Vascular by 4.4% during the second quarter. Dimensional Fund Advisors LP now owns 968,232 shares of the medical instruments supplier’s stock worth $30,228,000 after acquiring an additional 40,767 shares during the period. Finally, State Street Corp raised its position in LeMaitre Vascular by 25.2% during the second quarter. State Street Corp now owns 382,824 shares of the medical instruments supplier’s stock worth $11,951,000 after acquiring an additional 77,009 shares during the period. Hedge funds and other institutional investors own 71.62% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece was published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The correct version of this piece can be accessed at https://www.watchlistnews.com/lemaitre-vascular-lmat-upgraded-to-hold-at-bidaskclub/1843391.html.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment.

Analyst Recommendations for LeMaitre Vascular (NASDAQ:LMAT)

Receive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.